Search
×
FR

Placeholder headline

This is just a placeholder headline

API TR 5C3: Calculating Performance Properties of Pipe Used as Casing or Tubing

$

422

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 671: Special Purpose Couplings for Petroleum, Chemical and Gas Industry Services

$

502

BUY NOW

Placeholder headline

This is just a placeholder headline

Technical Report API TBD-10: Chapter 10 Surface and Interfacial Tension

$

176

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 671: Special Purpose Couplings for Petroleum, Chemical and Gas Industry Services: Errata 2

$

0

BUY NOW

Placeholder headline

This is just a placeholder headline

MSS SP-44-2026: Steel Pipeline Flanges

$

450

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 576: Inspection of Pressure-relieving Devices

$

460

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 591: Process Valve Qualification Procedure

$

226

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 576: Inspection of Pressure-relieving Devices: Addendum 1

$

0

BUY NOW

ISO 10993:2010

ISO 10993:2010 Biological evaluation of medical devices – Part 13: Identification and quantification of degradation products from polymeric medical devices

CDN $173.00

SKU: 04aff1cb6fe1 Categories: ,

Description

ISO 10993‚Äë13:2010 provides general requirements for the design of tests in a simulated environment for identifying and quantifying degradation products from finished polymeric medical devices ready for clinical use.

ISO 10993‚Äë13:2010 describes two test methods to generate degradation products, an accelerated degradation test as a screening method and a real-time degradation test in a simulated environment. For materials that are intended to polymerize in situ, the set or cured polymer is used for testing. The data generated are used in the biological evaluation of the polymer. ISO 10993‚Äë13:2010 considers only non-resorbable polymers. Similar, but appropriately modified procedures may be applicable for resorbable polymers.

ISO 10993‚Äë13:2010 considers only those degradation products generated by a chemical alteration of the finished polymeric device. It is not applicable to degradation of the device induced during its intended use by mechanical stress, wear or electromagnetic radiation or biological factors such as enzymes, other proteins and cellular activity.

Edition

2

Published Date

2010-06-04

Status

PUBLISHED

Pages

14

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

ISO 10993‚Äë13:2010 provides general requirements for the design of tests in a simulated environment for identifying and quantifying degradation products from finished polymeric medical devices ready for clinical use.

ISO 10993‚Äë13:2010 describes two test methods to generate degradation products, an accelerated degradation test as a screening method and a real-time degradation test in a simulated environment. For materials that are intended to polymerize in situ, the set or cured polymer is used for testing. The data generated are used in the biological evaluation of the polymer. ISO 10993‚Äë13:2010 considers only non-resorbable polymers. Similar, but appropriately modified procedures may be applicable for resorbable polymers.

ISO 10993‚Äë13:2010 considers only those degradation products generated by a chemical alteration of the finished polymeric device. It is not applicable to degradation of the device induced during its intended use by mechanical stress, wear or electromagnetic radiation or biological factors such as enzymes, other proteins and cellular activity.

Previous Editions

Can’t find what you are looking for?

Please contact us at: